Publications by authors named "P Yerly"
Article Synopsis
- * Potential causes of this syndrome include chronic thromboembolic pulmonary disease, necessitating specialized testing like echocardiography and pulmonary scintigraphy.
- * It's crucial to identify this condition, as around 20% of patients may still feel symptoms like exertional dyspnea, requiring tailored management strategies.
Introduction: Real-world outcomes with the HeartMate 3 left ventricular assist device (LVAD) depending on whether it's a bridge to transplantation (BTT) or destination therapy (DT) are poorly studied. We aimed to compare the profile and clinical outcomes of patients supported with HeartMate 3 according to a BTT or a DT pre-implantation strategy.
Methods: All patients consecutively implanted with HeartMate 3 at our centre (University Hospital of Lausanne, Switzerland) in 2015-2022 were analysed in a retrospective observational study.
Article Synopsis
- The study examined the impact of different cardiac preservation solutions on heart transplant outcomes, specifically comparing St-Thomas and HTK-Custodiol solutions over a period from 2009 to 2020.
- In patients receiving the HTK-Custodiol solution, results showed significantly lower inotropic scores, rejection scores, and 30-day mortality rates compared to the St-Thomas group.
- The use of HTK-Custodiol was associated with improved midterm survival rates, indicating it may be a more effective solution for myocardial protection during heart transplantation.